Trial · NCT03681093
Results by group12
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 12 of 12
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in Nasal Polyp Score at Week 16 | Fevipiprant 150 mg | 0.20 | Standard Error 0.224 | score on scale | |
| Change From Baseline in Nasal Polyp Score at Week 16 | Fevipiprant 450 mg | -0.10 | Standard Error 0.216 | score on scale | |
| Change From Baseline in Nasal Polyp Score at Week 16 | Placebo | 0.14 | Standard Error 0.233 | score on scale | |
| Change From Baseline in Nasal Congestion Score at Week 16 | Fevipiprant 150 mg | -0.15 | Standard Error 0.172 | score on scale | |
| Change From Baseline in Nasal Congestion Score at Week 16 | Fevipiprant 450 mg | -0.35 | Standard Error 0.171 | score on scale | |
| Change From Baseline in Nasal Congestion Score at Week 16 | Placebo | -0.80 | Standard Error 0.181 | score on scale | |
| Change From Baseline in Quality of Life as Assessed by the SNOT-22 Questionnaire at Week 16 | Fevipiprant 150 mg | -3.23 | Standard Error 3.349 | score on scale | |
| Change From Baseline in Quality of Life as Assessed by the SNOT-22 Questionnaire at Week 16 | Fevipiprant 450 mg | -10.61 | Standard Error 3.358 | score on scale | |
| Change From Baseline in Quality of Life as Assessed by the SNOT-22 Questionnaire at Week 16 | Placebo | -8.44 | Standard Error 3.571 | score on scale | |
| Change From Baseline in Sense of Smell as Assessed by the University of Pennsylvania Smell Identification Test (UPSIT) at Week 16 | Fevipiprant 150 mg | 1.05 | Standard Error 1.242 | score on scale | |
| Change From Baseline in Sense of Smell as Assessed by the University of Pennsylvania Smell Identification Test (UPSIT) at Week 16 | Fevipiprant 450 mg | 4.95 | Standard Error 1.259 | score on scale | |
| Change From Baseline in Sense of Smell as Assessed by the University of Pennsylvania Smell Identification Test (UPSIT) at Week 16 | Placebo | 0.44 | Standard Error 1.315 | score on scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03681093/results